 |
|
| Parkinson's Disease Clinical Trials For posting and discussion of clinical trials related to Parkinson's Disease, and for the Parkinson Pipeline Project. All are welcome. |
| Reply |
|
|
Thread Tools | Display Modes |
07-02-2008, 07:51 AM
|
#1 | |||
|
||||
|
Senior Member
|
Titan Pharmaceuticals Announces Spheramine(R) Initial Phase IIb Results
07.02.08, 7:01 AM ET Titan Pharmaceuticals, Inc. (AMEX:TTP) today announced initial analyses show that Spheramine(R) did not meet the Phase IIb clinical study's primary or key secondary endpoints, with no significant differences detected between the Spheramine and sham surgery arms of the study after 12 months of follow-up. The Phase IIb trial was designed to explore the safety, tolerability and efficacy of Spheramine, the company's novel cell-based therapy for the potential treatment of moderate to advanced Parkinson's disease. read the entire article http://www.forbes.com/businesswire/f...2005205r1.html
__________________
Jean B This isn't the life I wished for, but it is the life I have. So I'm doing my best. |
|||
|
 Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Spheramine(R): did not meet Phase IIb study's primary or key sec endpoints | Parkinson's Disease | |||
| 5 Phase bone scan study | Reflex Sympathetic Dystrophy (RSD and CRPS) | |||
| Phase II Spheramine trials complete enrollment | Parkinson's Disease | |||
| Spheramine Phase 2, Patient no. 1, he says .. | Parkinson's Disease | |||
Spheramine(r) phase IIB study did not meet endpoints
Linear Mode
